Related Experiment Video
Updated: Jan 9, 2026

Large-Scale Preparation of Synovial Fluid Mesenchymal Stem Cell-Derived Exosomes by 3D Bioreactor Culture
Published on: July 26, 2022
Application of stem cell-derived exosomes in bone and joint diseases: Recent advances enabled by diverse carrier
Ya-Jun Fu1, Jie Jian2, Can Liu1
1Department of Anatomy, Hunan Normal University, Changsha 410013, Hunan Province, China.
Abstract:
Bone and joint diseases, such as osteoarthritis, exhibit significant pathological complexity. Current treatment modalities possess notable limitations, driving the development of cell-free regenerative treatment strategies centered on stem cell-derived exosomes, particularly mesenchymal stem cell-derived exosomes. Despite the promise of mesenchymal stem cell-derived exosomes, several challenges impede their clinical translation. These include rapid in vivo clearance of exosomes, insufficient targeting specificity, and the difficulty of dynamically regulating the pathological microenvironment with a single delivery approach. In recent years, optimizing exosome functionality and achieving precise delivery through carrier technologies has emerged as a pivotal strategy to overcome these barriers. This review systematically evaluates the latest advancements in cutting-edge carrier technologies. These encompass biomaterial scaffolds (e.g., three-dimensional bio-printed GA/HA composite scaffolds), hydrogels, engineered and modified exosomes (e.g., cartilage affinity peptide CAP-exoASO), and nanomicrosphere co-loading systems. Research findings demonstrate that these carrier technologies enhance cartilage repair and anti-inflammatory effects via multiple mechanisms, including extending the half-life of exosomes, improving cartilage-targeting specificity, and enabling synergistic immune regulation, such as promoting M2 macrophage polarization. Preclinical studies have validated the potential of these carrier technologies. However, critical issues remain, including standardizing production processes, ensuring long-term biological safety, and evaluating cross-species efficacy. Looking ahead, multimodal delivery systems integrating gene editing, intelligent responsive materials, and personalized treatment strategies are expected to revolutionize bone and joint disease treatment by transitioning from symptom alleviation to functional reconstruction.
More Related Videos
10:30Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications
Published on: December 8, 2016
08:43Recombinant Collagen I Peptide Microcarriers for Cell Expansion and Their Potential Use As Cell Delivery System in a Bioreactor Model
Published on: February 7, 2018
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Mesenchymal Stem Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Clinical Applications of Epidermal Stem Cells
Stem Cell Culture